chrisvoncsefalvay/vaers-outcomes huggingface dataset:
soreness in her left arm where she received the injection; Fever; Shivering; Mild nausea; first dose of Shingrix on January 24th 2020 / second dose of Shingrix on 9/23/2020 /  due to "circumstances."; This case was reported by a other health professional via call center representative and described the occurrence of pain in arm in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received on 24th January 2020, refer case US2020AMR194760).   On 23rd September 2020, the patient received the 2nd dose of Shingrix. On 23rd September 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, fever, shivering, nausea and drug dose administration interval too long. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, fever, shivering and nausea were recovered/resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the pain in arm, fever, shivering and nausea to be related to Shingrix.  Additional details were reported as follows: The patient received the 2nd dose of Shingrix and on the same day, experienced soreness in her left arm where she received the injection, fever, shivering, and mild nausea. Reporter stated patient was late getting the 2nd dose due to circumstances, which led to lengthening of vaccination schedule. Reporter wanted to know if Tylenol lessened the effect of Shingrix, and if there was a titer for the Shingrix injections. The reporter was provided with Medical Disclaimer, PI in content, and the number to the MI department.   The reporter did not consented to follow-up.
Pt's mom was holdinf child advising him not to look at the needle, he turned and looked just as the injection was being administered, he became rigid then passed out for approximately 20 seconds had circumoral cyanosis which resolved quickly once air way opened,. Pt was pt was diaphoretic after the episode, was treated with cooling fan and sips of orange juice administered by pharmacist
Pain in arms; Movement difficulty; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arms) and MOVEMENT DISORDER (Movement difficulty) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arms) and MOVEMENT DISORDER (Movement difficulty). At the time of the report, PAIN IN EXTREMITY (Pain in arms) and MOVEMENT DISORDER (Movement difficulty) had not resolved.
About 4 days (around May 30th) after vaccination my right foot started having burning, numbness and pain. I was already having the same exact symptoms in my left foot from a previous vaccine (dose 2 Pfizer). I also had weakness in my arms and legs for 2-3 days. I just generally felt worse than after my previous vaccines. Then I noticed pain and burning in my perineal area. I also had a couple of episodes of fatigue and slight nausea that came and went, usually lasting about a day. I went to my primary care physician in mid-late July 2022 and they ordered alot of bloodwork that all came back fine. I seen a urologist on 8-17 and there was no infection. They did suggest that I take herbal meds like AZO and probiotics. I also went to an urgent care for a gynecology assessment on 8-23 with no known diagnosis. They prescribed Doxycycline and Fluconazole until the results of the papsmear came back. They later called me and told me to stop these medications due to normal results. On 8-26, I had acupuncture for these same symptoms. I have a call in to my primary care doctor as I want a referral to a neurologist.
Within 15 minutes, patient experienced itchy, tight throat "felt like a tickle in throat". Airway remained patent. No rash/hives.
presented initially to ED with gen weakness, sob. Pt found to have acute hypoxemic resp failure secondary to covid-19 pneumonia. Pt decompensated quickly upon coming to ED, and was subsequently intubated on 1/12/22. Crit care was consulted, as well as ID.  Pt developed septic shock, and was started on Levophed. Pt also was found to have rhabdomyolysis, and AKI; nephrology, was consulted. Ddimer was 1.75 upon admission, but, due to renal function, was unable to obtain CTA chest to evaluate for PE (and we do not have VQ scan capability here) , so pt was started on full dose Lovenox. However, pt developed LLQ abd hematoma with tracking to scrotum with subsequent acute blood loss anemia. Pt transfused 1 unit of PRBC on 1/18/22, and another unit on 1/19/22. Pt's H/H stabilized. Pt was ultimately discharged for higher level of care given need for possible IR intervention including embolization.
About an hour and a half after the shot, I felt slightly lightheaded (Saturday)  Mid-morning the next day I felt slightly lightheaded.  Monday, and through most of the following Saturday, I experienced nausea, lightheadedness and at times weakness in my legs.  The total number of days my symptoms lasted was 7 days.  The lightheadedness and weakness in my legs would come and go.  The nausea would last longer throughout the day.  There were times when I felt fine, but usually the nausea occurred most of the day.  At first eating crackers or dry food would help the nausea, but by day 4 post shot, the dry foods did little to help.
blood blister; one has a crack in one of the bumps and they hurt; blister on her lip makes it hard for her to talk; 6 spots on her lip that are red; 6 spots on her lip that are raised; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD BLISTER (blood blister), LIP PAIN (one has a crack in one of the bumps and they hurt), LIP BLISTER (blister on her lip makes it hard for her to talk), LIP ERYTHEMA (6 spots on her lip that are red) and LIP SWELLING (6 spots on her lip that are raised) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included MELATONIN for Sleep disorder.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced BLOOD BLISTER (blood blister), LIP PAIN (one has a crack in one of the bumps and they hurt), LIP BLISTER (blister on her lip makes it hard for her to talk), LIP ERYTHEMA (6 spots on her lip that are red) and LIP SWELLING (6 spots on her lip that are raised). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, BLOOD BLISTER (blood blister), LIP PAIN (one has a crack in one of the bumps and they hurt), LIP BLISTER (blister on her lip makes it hard for her to talk), LIP ERYTHEMA (6 spots on her lip that are red) and LIP SWELLING (6 spots on her lip that are raised) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs include: Bipolar Medication, Depression Medication, Bladder Medication, Anxiety Medication. Treatment  include: Gargle with water
Tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058E21A, 024M20A and 058E21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN, LISINOPRIL, METFORMIN and METOPROLOL SUCCINATE for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced FATIGUE (Tired). At the time of the report, FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Oct-2021, Body temperature: 99.6 (High) temperature of the forehead was 93.9 and body temperature was 99.6 (taken under the tongue).         No treatment medication was reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Apr2021 as dose 1, single (Lot number: EW0162), in left arm and on 28May2021 as dose 2, single (Lot number: EW0167) at the age of 36 years, in left arm for covid-19 immunization. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient did not take any other medications/products within 2 weeks of starting COVID-19 treatment. The patient previously receives a COVID-19 Vaccine. Anti-viral details product: COVID 19 Treatment, brand: Paxlovid, treatment start date: 12Jul2022, treatment stop date: 16Jul2022.  No follow-up attempts are possible. No further information is expected.
Approximately 2 hrs after inject pt noticed swelling around eyes & asthma symptoms. Pt's eyes were swollen shut the following morning. Swelling & asthma resolved by noon on 9/3/2010.
right upper extremity DVT.  Symptoms began 5 days after receiving vaccine.  Presented with right arm redness and swelling.  Found to have DVT on Day 9 following vaccination.  Does have a previous history of provoked DVT (following leg fracture).  No known coagulation disorder and not on chronic anticoagulation.
I took the test on Friday morning. I was running around, and I had a chill and I got home, and I received my results via email. The results said I tested positive for COVID-19. The next day I felt fatigued and had a cough and didn't feel great. I called my doctor we talked about all the different options, and we decided that PAXLOVID would be a great idea. The symptoms went away pretty fast all but the fatigued was around for a while. That was it and now I would say I am back to myself.
After receiving the second COVID vaccine I am experiencing extreme fatigue and nausea.  It will be two weeks tomorrow since the vaccine and I can't get off the couch.  I can barely walk from the bedroom to the living room.  Food doesn't have its normal taste and I am eating very little due to nausea.
I had a sore throat, headache, cough, fever, and body aches. I test positive for COVID-19 and my doctor prescribed me Paxlovid. I think it helped with my symptoms. I have noticed my heart pounding since I had COVID-19.
This spontaneous case reported by a consumer, describes the occurrence of vaccination site pruritus (injection site itching) and vaccination site erythema (injection site redness) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 20, 2021, patient experienced vaccination site pruritus (injection site itching) and vaccination site erythema (injection site redness). At the time of the report, vaccination site pruritus (injection site itching) and vaccination site erythema (injection site redness) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant medications and treatment information not provided.
Physician Discharge Summary   Patient ID: MRN: Name:  Age: 85 y.o. Birthday:   Admit Date: 7/9/2022  4:11 PM Discharge Date:  7/18/2022 Unit: Admitting Physician:  Discharge Physician:  MD   Discharge Diagnosis: Principal Problem:   Cerebrovascular accident (CVA) due to embolism Active Problems:   COVID-19   Frequent falls   Hyponatremia   PAF (paroxysmal atrial fibrillation)       HPI:    Patient is a 85 y.o. female with PMH of CAD, AFib, HTN who presented with family d/t frequent falls.  Increasing frequency over the past two weeks, especially the last two days.  She has had some incontinence, not during falls but seems that patient knows she has to go but cannot control it.  She reports she does feel dizzy before she falls.  History is limited d/t confusion.  Incontinence does not seem to coincide with falls necessarily.  She has some shaking at rest per family but no seizure-like activity reported.   Hospital Course: No notes on file She was admitted to covid unit in airborne isolation after testting + for covid. She had mri of head that showed Right frontal infarct.  There is an infarct involving the left basal ganglia. Scattered small infarcts are seen in the subcortical white matter..she was given asa, statin. She was consulted with PT OT ST. Permissive HTN was observed. Echo showed EF of 50-55%    Carotid US showed: Greater than 69% stenosis of the left common carotid artery  2. 50-69% stenosis of the left internal carotid artery  3. No other areas of carotid arterial stenosis.  4. The vasculature demonstrates diffuse moderate atherosclerotic calcification.    She was seen by vascular surgery: Minimal carotid stenosis bilaterally. Suspect stenosis overestimated as velocities on duplex measured in cm/s on some films and m/s on others. No plans for intervention. Continue antiplatelet and statin therapy.    She has PAF. She was seen by cardiology. She was started on eliquis. After several days, she was started on antihypertensive. Xray of the right shoulder showed chronic rotator cuff tear. She is stable. She will be discharged to encompass today. Will follow up with cardiology for possible watchman.          Physical Exam on the Date of Discharge: Physical exam:  General Appearance: alert, NAD  Neck: no JVD, no LN enlargement  Lungs: clear, no wheezing   Heart: RRR, S1 S2 heard  Abdomen / GI: soft, non-tender, no ascites  Extremities / musculoskeletal:  edema, no synovitis   Skin: no rash, dry skin  Neuro: follows commands, moves extremities
Sharp pain in vein in the neck, about  5pm left side pain all the way down my left side. The neck swelled up and under arm. Then numbness started on left side and continues off and on
It was not known to Center and not reported by patient that she previously received Pfizer vaccine. She received Moderna vaccine on 3/18/21 with our agency. I received a fax today from pharmacy with Pfizer vaccine record thus the vaccine error was discovered.
Received immunizations 8/2/05. Also had a PPD given in left forearm. When client came in on 8/4/05 to have PPD read, she showed me redness and moderate swelling in left shoulder where Dtap was administered. She said she didn't notice until that morning.
Pt fainted a few minutes after shots. She awoke again right away, but did not respond to us for first couple seconds.  She then felt dizzy and nauseous. EMS was alerted and arrived. She felt ok at that point and did not go with ambulance.
About 4 hours after vaccination he started having seizures. He was between 15 and 18 months old at the time.
Severely swollen left arm. Small rash on left side of back. MOTRIN/BENADRYL/Prednisone (given by ER).
This non-spontaneous case, initially received on 19-Mar-2018, was reported by other health professional and concerns a 17-year-old adolescent patient of unspecified gender. It was reported that, on an unspecified date, the temperature of the refrigerator in which vaccine was stored dropped to 32 F and was out of range for a total of 1 hour and continued for 2 weeks. On 08-Feb-2018, the patient was administered FLUCELVAX QIV (dose, route of administration: intramuscular, anatomical location: left deltoid, batch number: 195236, expiry date: 30-May-2018) that was stored out of recommended temperature for an unknown indication. The patient had no adverse reactions from the suspect vaccine that underwent temperature excursion. Non-significant follow-up received on 07-May-2018: Upon internal review, it was realised that the expiry date was incorrect. Hence, the expiry date was changed from 31-May-2018 to 30-May-2018 in the product tab. The reporter confirmed that, the patient had no adverse reactions from the suspect vaccine that underwent temperature excursion. Narrative was amended accordingly.
This spontaneous report as received from a health professional via other company Pfizer (manufacturer control #2016222216) refers to a 61 year old Caucasian female patient. The patient's concurrent conditions included coronary artery disease, rheumatoid arthritis, seasonal allergy and hyperlipidaemia. The patient was immunocompromised. On 15-NOV-2015, the patient was vaccinated with the first dose of ZOSTAVAX (dose, route of administration, lot # and expiry date were not reported). The vaccine was given only once. Concomitant therapies included atorvastatin, methotrexate (manufacturer unknown) and loratadine (manufacturer unknown). On an unknown date in 2015, the patient experienced redness. The outcome of redness was unknown. The relatedness between the event of redness and ZOSTAVAX was not reported. Additional information has been requested.
Hospital visit, sepsis, pneumonia. All 2 days after vaccines - hospitalized and given antibiotics.
2/15/22 - first ED visit, child changed mentally. Unable to return to normal state after episode begins. Appears to have seizure like looks but it is not a seizure. She can not respond during these episodes and began to see and hear things that aren?t there.   2/1622- 2nd ED visit same symptoms. Unable to recover from onset of delirium.  2/17/22 - 3rd ED visit. Same symptoms. Yet again sent home.  2/18/22 -4th Ed visit. Same symptoms. Sent home again.  Was taken by ambulance. BP 179/110 Heart rate tachycardic.  2/19 - 5th ED visit. Admitted to Facility for testing and admission.  3/7/22 - daughter still undiagnosed and still having memory loss, regression, delirium in waves.  Up until last week was unaware of age,  year of birth, season, counting 1-10  Sudden onset of symptoms. Before February 15th 2022 my child never had neurological trouble. She was a straight ?A? student who was bright and happy. She has lost memory and regressed. She is still undiagnosed today. She woke up and was a different person. Who became unable to be touched or consoled.
I had painful and swollen lymph nodes in my left breast. I was extremely lethargic, very weak for at least 30 days. I just felt awful. I also experienced pneumonia twice this year and I've never had it before.
10 patients administered vaccine past the beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 patients administered vaccine past the beyond use date) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939905) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 patients administered vaccine past the beyond use date). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (10 patients administered vaccine past the beyond use date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  No treatment medications were provided by the reporter. This case concerns a 71-year-old, female patient, with no known medical history, who experienced the non-serious event of expired product administered. The event occurred  on the same day after unspecified dose of Moderna vaccine. The rechallenge is not applicable due to the nature of the event. The benefit-risk relationship of Moderna vaccine is not affected by this report.; Sender's Comments: This case concerns a 71-year-old, female patient, with no known medical history, who experienced the non-serious event of expired product administered. The event occurred  on the same day after unspecified dose of Moderna vaccine. The rechallenge is not applicable due to the nature of the event. The benefit-risk relationship of Moderna vaccine is not affected by this report.
This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and MYALGIA (body ache and pain) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), Blood thinners and ACETAMINOPHEN for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PYREXIA (Fever) and MYALGIA (body ache and pain). At the time of the report, PYREXIA (Fever) and MYALGIA (body ache and pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included anti-fever medication.
Recvd inject Wedesday evening slept all night, no problems; started running temp @ 10AM on Thursday 103.7 R; APAP given w/poor results-bath reduced temp to 101 but inc back to 103.7 shortly; vomiting & diarrhea-couldn't keep forumula down
Broke out in rash yesterday - rash all over body - no itching or apparent discomfort at this time. Gave Benadryl Elixir 4oz/IRF 1/2 tsp PO q 6 hrs prn (generalized erythematous maculo-papular rash)
I live with MS and the vaccine caused the nerves in my back side to continuosly fire, causing excrutiating pain. Ot started on 6/9/21 @3am and is still going at 130pm.
11/15/2021 I woke up feeling like I have a cold, watery eyes, coughing, and runny nose- lasted for 4/5 days.
Patient received vaccine on 3/10/14 and she had muscle weakness head to toe for 2 weeks after injection.
pt recv vax 4FEB97 rt deltoid on 23FEB97 varicella rash appeared;2MAR97 lesion drying;calamine lotion to lesion